{"id":104446,"date":"2025-05-15T20:43:11","date_gmt":"2025-05-15T20:43:11","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/104446\/"},"modified":"2025-05-15T20:43:11","modified_gmt":"2025-05-15T20:43:11","slug":"hhs-chief-rfk-jr-says-hes-ordered-a-complete-review-of-chemical-abortion-pill","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/104446\/","title":{"rendered":"HHS chief RFK Jr. says he\u2019s ordered a \u2018complete review\u2019 of chemical abortion pill"},"content":{"rendered":"

Health and Human Services Secretary Robert F. Kennedy Jr. revealed Wednesday that he has ordered the Food and Drug Administration (FDA) to conduct a \u201ccomplete review\u201d of a chemical abortion pill amid reports that the drug isn\u2019t as safe as advertised<\/a>.\u00a0\u00a0<\/p>\n

\u201cIt\u2019s alarming,\u201d RFK Jr. said of a recent study conducted by the Ethics & Public Policy Center that found nearly 11% of women who used the popular abortion pill mifepristone<\/a> experienced a \u201cserious adverse event.\u201d\u00a0<\/p>\n

\u201cI have asked Marty Makary<\/a>, who is the director at FDA, to do a complete review and report back,\u201d the HHS secretary revealed during a Senate Health, Labor, Education and Pensions Committee hearing.\u00a0<\/p>\n

The FDA will conduct a \u201ccomplete review\u201d of mifepristone after reports that the drug isn\u2019t as safe as advertised. REUTERS<\/p>\n

The Ethics & Public Policy Center study<\/a> \u2013 the \u201clargest-known\u201d on the abortion pill \u2013 analyzed insurance claims data from 865,727 prescribed mifepristone abortions between 2017 and 2023.\u00a0<\/p>\n

The study found 10.93% of women experience sepsis, infection, hemorrhaging, or another serious adverse event within 45 days following a mifepristone abortion.<\/p>\n

Sen. Josh Hawley (R-Mo.)<\/a> cited the group\u2019s research as he questioned RFK Jr. during the hearing and noted that the study showed the rate of serious adverse health effects \u201cis 22 times higher than the FDA\u2019s current label\u201d for mifepristone, \u201cwhich says it\u2019s just 0.5%.\u201d<\/p>\n

\u201cClearly [the study] indicates, at the very least, that the label should be changed,\u201d Kennedy Jr. told Hawley.\u00a0<\/p>\n

Mifepristone was originally approved by the FDA in 2000.<\/p>\n

Health and Human Services Secretary Robert F. Kennedy Jr. ordered the FDA to review mifepristone after reports of safety concerns. Jack Gruber-USA TODAY via Imagn Images<\/p>\n

Demonstrators rallied in support of abortion rights at the US Supreme Court in Washington, DC, on April 15, 2023. AFP via Getty Images<\/p>\n

The Ethics & Public Policy Center, which released its findings last month, argued that the FDA should implement \u201cstronger patient safety protocols to ensure physician responsibility for women who take mifepristone under their care, as well as mandate full reporting of its side effects,\u201d in light of its study.<\/p>\n

\u201cThe FDA should further investigate the harm mifepristone causes to women and, based on objective safety criteria, reconsider its approval altogether,\u201d the group concluded.\u00a0<\/p>\n

The FDA initially OK\u2019d mifepristone for chemical abortions up to seven weeks into a pregnancy \u2014 a timeframe that was later extended to 10 weeks under former President Barack Obama.<\/p>\n

Former President Joe Biden opened the door to FDA approval of mifepristone prescriptions online or through the mail, which the Supreme Court upheld<\/a> in a unanimous ruling last year.<\/p>\n

The Washington, DC-based Ethics and Public Policy Center is a conservative think tank and advocacy group that seeks \u201cto apply the riches of the Jewish and Christian traditions to contemporary questions of law, culture, and politics, in pursuit of America\u2019s continued civic and cultural renewal,\u201d according to the group\u2019s website.<\/p>\n","protected":false},"excerpt":{"rendered":"Health and Human Services Secretary Robert F. Kennedy Jr. revealed Wednesday that he has ordered the Food and…\n","protected":false},"author":2,"featured_media":104447,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4315],"tags":[26054,8179,2460,105,35449,4326,285,17287,8180,16,15,727],"class_list":{"0":"post-104446","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-abortion","9":"tag-congress","10":"tag-fda","11":"tag-health","12":"tag-health-and-human-services","13":"tag-medication","14":"tag-politics","15":"tag-robert-f-kennedy-jr","16":"tag-senate","17":"tag-uk","18":"tag-united-kingdom","19":"tag-us-news"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/114513799230741974","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/104446","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=104446"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/104446\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/104447"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=104446"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=104446"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=104446"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}